Ariya Neuro Care has been acquired by Choice Care
April 2026 — Ariya Neuro Care had been sold to Choice Care, a leading provider of specialist care and services for people with learning disabilities, autism and mental health needs. Both organizations share a strong commitment to high-quality, person-centered care, grounded in compassion, integrity and a belief in the potential of every individual. This alignment was a key consideration for Ariya’s founders in selecting a partner.
Ariya is a specialist provider of brain injury rehabilitation services, supporting people with complex physical and cognitive needs following life-changing injuries. The company focuses on transitional neurorehabilitation and community-based support, helping people develop the skills and strategies needed to adjust, rebuild independence, self-esteem and meaningful lives.
Choice Care is a leading UK specialist care provider offering residential and supported living services to adults with learning disabilities and mental health conditions. The company is backed by investment firm iCON Infrastructure.
Our role in the transaction
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised the shareholders of Ariya on its sale to Choice Care.
Paul Constable
Managing director and founder, Ariya Neuro Care
Talk to the deal team
Related deals
Indigo Capital has acquired a minority stake in Vivason
Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more